Global Tuberculosis (TB) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Tuberculosis (TB) Treatment Market Overview

• 1.1 Product Overview and Scope of Tuberculosis (TB) Treatment
• 1.2 Classification of Tuberculosis (TB) Treatment by Types
  • 1.2.1 Global Tuberculosis (TB) Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Isoniazid
  • 1.2.4 Rifampin (Rifadin, Rimactane)
  • 1.2.5 Ethambutol (Myambutol)
  • 1.2.6 Pyrazinamide
• 1.3 Global Tuberculosis (TB) Treatment Market by Application
  • 1.3.1 Global Tuberculosis (TB) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Active TB
  • 1.3.3 Latent TB
• 1.4 Global Tuberculosis (TB) Treatment Market by Regions
  • 1.4.1 Global Tuberculosis (TB) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Tuberculosis (TB) Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis (TB) Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis (TB) Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis (TB) Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis (TB) Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Tuberculosis (TB) Treatment (2014-2024)

2 Company Profiles

• 2.1 Johnson & Johnson
  • 2.1.1 Business Overview
  • 2.1.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Sanofi
  • 2.2.1 Business Overview
  • 2.2.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Sanofi Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Dong-A ST Co., Ltd
  • 2.3.1 Business Overview
  • 2.3.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Otsuka Pharmaceutical Co., Ltd
  • 2.4.1 Business Overview
  • 2.4.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Mylan
  • 2.5.1 Business Overview
  • 2.5.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Mylan Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Macleods Pharmaceutical Ltd
  • 2.6.1 Business Overview
  • 2.6.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Janssen Products, LP
  • 2.7.1 Business Overview
  • 2.7.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Janssen Products, LP Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Lupin Ltd
  • 2.8.1 Business Overview
  • 2.8.2 Tuberculosis (TB) Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Lupin Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Tuberculosis (TB) Treatment Market Competition, by Players

• 3.1 Global Tuberculosis (TB) Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Tuberculosis (TB) Treatment Players Market Share
  • 3.2.2 Top 10 Tuberculosis (TB) Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Tuberculosis (TB) Treatment Market Size by Regions

• 4.1 Global Tuberculosis (TB) Treatment Revenue and Market Share by Regions
• 4.2 North America Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

5 North America Tuberculosis (TB) Treatment Revenue by Countries

• 5.1 North America Tuberculosis (TB) Treatment Revenue by Countries (2014-2019)
• 5.2 USA Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

6 Europe Tuberculosis (TB) Treatment Revenue by Countries

• 6.1 Europe Tuberculosis (TB) Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Tuberculosis (TB) Treatment Revenue by Countries

• 7.1 Asia-Pacific Tuberculosis (TB) Treatment Revenue by Countries (2014-2019)
• 7.2 China Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

8 South America Tuberculosis (TB) Treatment Revenue by Countries

• 8.1 South America Tuberculosis (TB) Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Tuberculosis (TB) Treatment by Countries

• 9.1 Middle East and Africa Tuberculosis (TB) Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Tuberculosis (TB) Treatment Revenue and Growth Rate (2014-2019)

10 Global Tuberculosis (TB) Treatment Market Segment by Type

• 10.1 Global Tuberculosis (TB) Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Tuberculosis (TB) Treatment Market Forecast by Type (2019-2024)
• 10.3 Isoniazid Revenue Growth Rate (2014-2024)
• 10.4 Rifampin (Rifadin, Rimactane) Revenue Growth Rate (2014-2024)
• 10.5 Ethambutol (Myambutol) Revenue Growth Rate (2014-2024)
• 10.6 Pyrazinamide Revenue Growth Rate (2014-2024)

11 Global Tuberculosis (TB) Treatment Market Segment by Application

• 11.1 Global Tuberculosis (TB) Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Tuberculosis (TB) Treatment Market Forecast by Application (2019-2024)
• 11.3 Active TB Revenue Growth (2014-2019)
• 11.4 Latent TB Revenue Growth (2014-2019)

12 Global Tuberculosis (TB) Treatment Market Size Forecast (2019-2024)

• 12.1 Global Tuberculosis (TB) Treatment Market Size Forecast (2019-2024)
• 12.2 Global Tuberculosis (TB) Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Tuberculosis (TB) Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Tuberculosis (TB) Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Tuberculosis (TB) Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Tuberculosis (TB) Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Tuberculosis (TB) Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology